홈 › 만성 폐쇄성 폐질환 › 미주리
미주리의 만성 폐쇄성 폐질환 임상 시험
만성 폐쇄성 폐질환 관련 연구 10개가 미주리 내 여러 지역에서 참여자를 모집하고 있습니다.
미주리의 도시
공식 연구 텍스트(영어)
Rademikibart IV for Acute Asthma and COPD Exacerbation
- Washington University- Cardiovascular Imaging and Clinical Research Core Laboratory, St Louis
피험자 모집 중2상
18세 ~ 85세 · 모든 성별 · 2026. 11. 4. 업데이트됨 · NCT07705737To Evaluate the Effect of EXPD-101/FXS7553 Compared With Placebo in Patients With COPD Over 52 Weeks of Treatment
- Hannibal Regional Healthcare System, Inc., Hannibal
피험자 모집 중2상
40세 ~ 85세 · 모든 성별 · 2026. 10. 28. 업데이트됨 · NCT07684820A Study to Investigate the Effect of AZD6793 in Participants With Moderate to Very Severe Chronic Obstructive Pulmonary Disease
- Research Site, Chesterfield
- Research Site, Hannibal
- Research Site, St Louis
- 외 1개
피험자 모집 중2상
40세 이상 · 모든 성별 · 2026. 10. 23. 업데이트됨 · NCT07082738Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD), Characterized by an Eosinophilic Phenotype
- Hannibal Regional Healthcare System- Site Number : 8400035, Hannibal
- Washington University- Site Number : 8400144, St Louis
피험자 모집 중3상
40세 ~ 80세 · 모든 성별 · 2026. 10. 23. 업데이트됨 · NCT07190222A Study to Learn About the Study Medicine Called PF-07275315 in People With Moderate to Severe Chronic Obstructive Pulmonary Disease
- Washington University School of Medicine, St Louis
- Barnes-Jewish Hospital Investigational Drug Service, St Louis
- Barnes-Jewish Hospital, St Louis
- 외 2개
피험자 모집 중2/3상
35세 ~ 80세 · 모든 성별 · 2026. 10. 22. 업데이트됨 · NCT07363694A Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD (D5241C00007)
- Research Site, Hannibal
피험자 모집 중3상
40세 ~ 80세 · 모든 성별 · 2026. 10. 9. 업데이트됨 · NCT06878261Depemokimab as an Extended Treatment Duration Biologic in Adults With Chronic Obstructive Pulmonary Disease (COPD) and Type 2 Inflammation
- GSK Investigational Site, St Louis
피험자 모집 중3상
40세 ~ 80세 · 모든 성별 · 2026. 10. 5. 업데이트됨 · NCT06959095A Study Evaluating the Efficacy of Budesonide, Glycopyrronium and Formoterol Fumarate Metered Dosed Inhaler on Cardiopulmonary Outcomes in Chronic Obstructive Pulmonary Disease
- Research Site, St Louis
피험자 모집 중3상
40세 ~ 80세 · 모든 성별 · 2026. 10. 2. 업데이트됨 · NCT06283966Nebulizer Versus Handheld Maintenance Therapy for Patients With COPD
- Midwest Chest Consultants, P.C., Saint Charles
피험자 모집 중4상
60세 이상 · 모든 성별 · 2026. 9. 14. 업데이트됨 · NCT07816835A Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD (D5241C00006)
- Research Site, St Louis
피험자 모집 중3상
40세 ~ 80세 · 모든 성별 · 2026. 9. 3. 업데이트됨 · NCT06883305ClinicalTrials.gov 출처, 2026. 11. 15. 기준 데이터입니다. 각 연구는 자체적인 자격 기준을 설정하며, 연구 팀이 참여자를 결정합니다.